Phlebotomy as an efficient long-term treatment of congenital erythropoietic porphyria

Ítems similars

• Erythroid-Progenitor-Targeted Gene Therapy Using Bifunctional TFR1 Ligand-Peptides in Human Erythropoietic Protoporphyria
  per: Mirmiran, Arienne, et al.
  Publicat: (2019)
• Identification of novel UROS mutations in a patient with congenital erythropoietic porphyria and efficient treatment by phlebotomy
  per: Blouin, Jean-Marc, et al.
  Publicat: (2021)
• Antisense Oligonucleotide-Based Therapy in Human Erythropoietic Protoporphyria
  per: Oustric, Vincent, et al.
  Publicat: (2014)
• Role of phlebotomy in the treatment of liver damage related to erythropoietic porphyria
  per: Satoru Hagiwara, et al.
  Publicat: (2022-04-01)
• A mutation in the iron-responsive element of ALAS2 is a modifier of disease severity in a patient suffering from CLPX associated erythropoietic protoporphyria
  per: Ducamp, Sarah, et al.
  Publicat: (2021)